The webinar will enable Health care professionals managing patients with Parkinsons disease, to identify issues and improve quality of life, particularly in the areas of sleep and sexual issues. From the mechanism and science behind sleep issues in PD and how to address these, to understanding, discussing and implementing practical advice on the sexual issues faced by patients with Parkinsons, often a difficult discussion to have, particularly when the pandemic has interrupted face to face consultations. The webinar will also look at patient management in the pandemic and identify areas which, although, not anticipated, may have improved patient outcomes.
Founded in 1924, BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 55 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world.
Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D programme. Key focus areas for the Group are the neurosciences and cardiovascular. The Bial team currently consists of 900 workers. We bring together our knowledge, experience, imagination and dedication to achieve a concrete goal: providing high quality medicines. 79% of our workers have higher education qualifications, 7% of which are PhDs.
